# CaMKII as a Multimodal Signalling Hub in Neural Connectivity and Vulnerability

**Authors:** Stephanie Olliff, Vinod Sundaramoorthy

PMC · DOI: 10.1007/s12035-026-05777-0 · 2026-03-18

## TL;DR

This paper explores how CaMKII, a key brain protein, functions as a complex signaling hub that influences neural connectivity and disease through multiple regulatory states.

## Contribution

The paper introduces a new conceptual framework for CaMKII as a multistate signaling hub rather than a simple bistable switch.

## Key findings

- CaMKII integrates catalytic, structural, and scaffolding roles influenced by phosphatases and spatial confinement.
- Disrupted CaMKII regulation contributes to neurodevelopmental and neurodegenerative disorders.
- CaMKII's isoform diversity allows specialized functions in different neuronal compartments.

## Abstract

Calcium/calmodulin-dependent protein kinase II (CaMKII) is one of the most abundant and versatile signalling molecules in the brain, uniquely positioned to convert transient signals into durable structural and functional changes. Classical models cast CaMKII as a Ca2+/calmodulin-activated kinase that, once phosphorylated, persists autonomously to encode synaptic memory. Recent work has reframed this view, revealing CaMKII as a state and context-dependent signalling hub that integrates catalytic activity with structural and scaffolding functions. Its activity and persistence are shaped by partner protein interactions, higher-order assembly, redox and metabolic modifications, and confinement within nanoscale domains. Isoform and splice diversity further distribute CaMKII into specialised pools across dendritic spines, growth cones, axons, and nuclei, enabling it to regulate synaptic plasticity, axon growth, and long-term neuronal stability through both enzymatic and non-enzymatic mechanisms. These actions are dynamically sculpted by opposing phosphatases, including PP1, PP2A, and calcineurin, which do not simply terminate signalling but bias the kinase toward kinetically stabilised functional configurations with distinct catalytic and structural outputs. Here we outline a conceptual multistate regulatory framework in which CaMKII can occupy basal, catalytically active, and structurally stabilised functional regimes, rather than operating as a simple bistable switch. In this framework, these regimes are defined by differences in signalling persistence and molecular interactions rather than by formally demonstrated stable attractors, providing a functional model for understanding how CaMKII integrates spatially restricted Ca2+ signals with phosphatase control. Disruption of regulated transitions between these regimes through altered phosphatase balance, aberrant spatial confinement, or pathological modification can shift CaMKII signalling into inappropriate compartments or timescales, contributing to neurodevelopmental, psychiatric, and neurodegenerative disorders. This review highlights recent advances in activation mechanisms, isoform-specific organisation, phosphatase control, and disease biology, positioning CaMKII as a hybrid structural–catalytic integrator whose state-dependent regulation offers new opportunities for precision therapeutic intervention.

## Linked entities

- **Genes:** CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818]
- **Proteins:** CAMK2G (calcium/calmodulin dependent protein kinase II gamma), PPA1 (inorganic pyrophosphatase 1), PTPA (protein phosphatase 2 phosphatase activator), ppp3ca.S (protein phosphatase 3, catalytic subunit, alpha isozyme S homeolog)

## Full-text entities

- **Genes:** Rasa1 (RAS p21 protein activator 1) [NCBI Gene 218397] {aka Gap, RasGAP, Rasa}, Calm2 (calmodulin 2) [NCBI Gene 12314] {aka 1500001E21Rik, Cam2, CamC}, Grin2b (glutamate receptor, ionotropic, NMDA2B (epsilon 2)) [NCBI Gene 14812] {aka GluN2B, GluRepsilon2, NR2B, Nmdar2b}, Cacng2 (calcium channel, voltage-dependent, gamma subunit 2) [NCBI Gene 12300] {aka B230105C07Rik, B930041E13Rik, stargazer, stargazin, stg, wag}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, Lrrc7 (leucine rich repeat containing 7) [NCBI Gene 242274] {aka B230334C09Rik, densin, mKIAA1365}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, PTPA (protein phosphatase 2 phosphatase activator) [NCBI Gene 5524] {aka PARK25, PP2A, PPP2R4, PR53}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Dlg1 (discs large MAGUK scaffold protein 1) [NCBI Gene 13383] {aka B130052P05Rik, Dlgh1, E-dlg/SAP97, SAP-97, SAP97, mKIAA4187}, Camk2g (calcium/calmodulin-dependent protein kinase II gamma) [NCBI Gene 12325] {aka Camkg}, Sarm1 (sterile alpha and HEAT/Armadillo motif containing 1) [NCBI Gene 237868] {aka A830091I15Rik, MyD885, Sarm}, Tiam1 (T cell lymphoma invasion and metastasis 1) [NCBI Gene 21844] {aka D16Ium10, D16Ium10e}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Map3k5 (mitogen-activated protein kinase kinase kinase 5) [NCBI Gene 26408] {aka 7420452D20Rik, ASK, ASK1, MAPKKK5, Mekk5}, Cask (calcium/calmodulin dependent serine protein kinase) [NCBI Gene 12361] {aka DXPri1, DXRib1, LIN-2, Pals3, mLin-2}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Syngap1 (synaptic Ras GTPase activating protein 1 homolog (rat)) [NCBI Gene 240057] {aka Gm1963, Syngap}, Arhgef2 (Rho/Rac guanine nucleotide exchange factor 2) [NCBI Gene 16800] {aka GEF, GEF-H1, GEFH1, LFP40, Lbcl1, Lfc}, Akap5 (A kinase anchor protein 5) [NCBI Gene 238276] {aka 3526401B18Rik, AKAP 150, AKAP-5, AKAP150, Gm258, P150}, Il2rg (interleukin 2 receptor, gamma chain) [NCBI Gene 16186] {aka CD132, [g]c, gamma(c), gc, p64}, Rac1 (Rac family small GTPase 1) [NCBI Gene 19353] {aka D5Ertd559e}, Actn2 (actinin alpha 2) [NCBI Gene 11472] {aka 1110008F24Rik}, Lrpap1 (low density lipoprotein receptor-related protein associated protein 1) [NCBI Gene 16976] {aka HBP44, RAP}, Itpr1 (inositol 1,4,5-trisphosphate receptor 1) [NCBI Gene 16438] {aka D6Pas2, Gm10429, IP3R 1, IP3R1, InsP3R, Ip3r}, Ppp2ca (protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform) [NCBI Gene 19052] {aka PP2A}, NPY4R (neuropeptide Y receptor Y4) [NCBI Gene 5540] {aka NPY4-R, PP1, PPYR1, Y4}, Atp9b (ATPase, class II, type 9B) [NCBI Gene 50771] {aka Atpc2b, IIb, MMR}, Ppp1cc (protein phosphatase 1 catalytic subunit gamma) [NCBI Gene 19047] {aka PP-1G, PP1, dis2m1}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Dlg4 (discs large MAGUK scaffold protein 4) [NCBI Gene 13385] {aka Dlgh4, PSD-95, PSD95, SAP90, SAP90A}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, Kcnd2 (potassium voltage-gated channel, Shal-related family, member 2) [NCBI Gene 16508] {aka Gm52855, Kv4.2}, Creb1 (cAMP responsive element binding protein 1) [NCBI Gene 12912] {aka 2310001E10Rik, 3526402H21Rik, Creb, Creb-1}, Grm5 (glutamate receptor, metabotropic 5) [NCBI Gene 108071] {aka 6430542K11Rik, Glu5R, Gprc1e, mGluR5, mGluR5b}, Msra (methionine sulfoxide reductase A) [NCBI Gene 110265] {aka 2310045J23Rik, 6530413P12Rik, MSR-A}
- **Diseases:** autism spectrum disorder (MESH:D000067877), Schizophrenia (MESH:D012559), depression (MESH:D003866), DISEASE (MESH:D004194), Epilepsy (MESH:D004827), retinal and optic nerve degeneration (MESH:D012162), brain disease (MESH:D001927), Parkinson's disease (MESH:D010300), Alzheimer's disease (MESH:D000544), synaptic dysfunction (MESH:C536122), Neurodegenerative disorders (MESH:D019636), Huntington's disease (MESH:D006816), axon degeneration (MESH:D009410), Neurological and Neurodegenerative Disorders (MESH:D020271)
- **Chemicals:** NAD (MESH:D009243), cholesterol (MESH:D002784), BioRender (-), Calcium (MESH:D002118), CoA (MESH:D003065), sphingolipid (MESH:D013107), ATP (MESH:D000255), lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** c.328G>A, Thr286Ala

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999712/full.md

---
Source: https://tomesphere.com/paper/PMC12999712